NCT07309770
- Conditions
- Adenocarcinoma, Advanced Solid Tumor Cancer, Antibody-drug Conjugates, +8 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Antibody-drug Conjugates
Explore clinical trials studying Antibody-drug Conjugates. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Antibody-drug Conjugates trial results
NCT07164950
- Conditions
- Advanced Solid Tumors, Antibody-drug Conjugates, Carcinoma, +6 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
NCT06877416
- Conditions
- Antibody-drug Conjugates, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Sun yat-sen University Cancer Guangzhou, Guangdong, China
Not Yet Recruiting
ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma
NCT07579598
- Conditions
- Adenoid Cystic Carcinoma of the Head and Neck, Antibody-drug Conjugates, SBRT
- Locations
-
Not specified
Not Yet Recruiting
MA-CRC-II-016 SHR-1811
NCT07355764
- Conditions
- Antibody-drug Conjugates, HER2, Targeted Therapy, +1 more
- Locations
-
Not specified
Not Yet Recruiting
Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression
NCT07168083
- Conditions
- Adnexal Diseases, Antibody-drug Conjugates, Clear Cell Adenocarcinoma of Ovary, +15 more
- Locations
-
Not specified